company background image
PDEX logo

Pro-Dex NasdaqCM:PDEX Stock Report

Last Price

US$44.29

Market Cap

US$144.4m

7D

-3.4%

1Y

138.0%

Updated

11 May, 2025

Data

Company Financials +

Pro-Dex, Inc.

NasdaqCM:PDEX Stock Report

Market Cap: US$144.4m

PDEX Stock Overview

Designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. More details

PDEX fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance4/6
Financial Health4/6
Dividends0/6

Rewards

Price-To-Earnings ratio (15.4x) is below the US market (17.5x)

Earnings grew by 358.8% over the past year

Risk Analysis

Earnings are forecast to decline by an average of 3.1% per year for the next 3 years

High level of non-cash earnings

Volatile share price over the past 3 months compared to the US market


Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

Pro-Dex, Inc. Competitors

Electromed

NYSEAM:ELMD

US$190.6m

Jin Medical International

NasdaqCM:ZJYL

US$129.9m

Tactile Systems Technology

NasdaqGM:TCMD

US$221.8m

Kewaunee Scientific

NasdaqGM:KEQU

US$99.6m

Price History & Performance

Summary of share price highs, lows and changes for Pro-Dex
Historical stock prices
Current Share PriceUS$44.29
52 Week HighUS$70.26
52 Week LowUS$16.84
Beta0.37
1 Month Change-29.95%
3 Month Change33.20%
1 Year Change137.99%
3 Year Change192.92%
5 Year Change161.14%
Change since IPO714.52%

Recent News & Updates

Here's Why Pro-Dex (NASDAQ:PDEX) Has Caught The Eye Of Investors

May 04
Here's Why Pro-Dex (NASDAQ:PDEX) Has Caught The Eye Of Investors

Pro-Dex, Inc.'s (NASDAQ:PDEX) P/E Is Still On The Mark Following 29% Share Price Bounce

Apr 16
Pro-Dex, Inc.'s (NASDAQ:PDEX) P/E Is Still On The Mark Following 29% Share Price Bounce

Recent updates

Here's Why Pro-Dex (NASDAQ:PDEX) Has Caught The Eye Of Investors

May 04
Here's Why Pro-Dex (NASDAQ:PDEX) Has Caught The Eye Of Investors

Pro-Dex, Inc.'s (NASDAQ:PDEX) P/E Is Still On The Mark Following 29% Share Price Bounce

Apr 16
Pro-Dex, Inc.'s (NASDAQ:PDEX) P/E Is Still On The Mark Following 29% Share Price Bounce

Pro-Dex (NASDAQ:PDEX) Looks To Prolong Its Impressive Returns

Apr 03
Pro-Dex (NASDAQ:PDEX) Looks To Prolong Its Impressive Returns

This Analyst Just Made A Decent Upgrade To Their Pro-Dex, Inc. (NASDAQ:PDEX) Earnings Forecasts

Feb 24
This Analyst Just Made A Decent Upgrade To Their Pro-Dex, Inc. (NASDAQ:PDEX) Earnings Forecasts

Some Pro-Dex, Inc. (NASDAQ:PDEX) Shareholders Look For Exit As Shares Take 27% Pounding

Feb 05
Some Pro-Dex, Inc. (NASDAQ:PDEX) Shareholders Look For Exit As Shares Take 27% Pounding

This Analyst Just Made A Massive Upgrade To Their Pro-Dex, Inc. (NASDAQ:PDEX) Earnings Forecasts

Nov 13
This Analyst Just Made A Massive Upgrade To Their Pro-Dex, Inc. (NASDAQ:PDEX) Earnings Forecasts

Pro-Dex, Inc. (NASDAQ:PDEX) Stock Rockets 31% As Investors Are Less Pessimistic Than Expected

Nov 05
Pro-Dex, Inc. (NASDAQ:PDEX) Stock Rockets 31% As Investors Are Less Pessimistic Than Expected

Pro-Dex, Inc.'s (NASDAQ:PDEX) P/E Is Still On The Mark Following 37% Share Price Bounce

Sep 10
Pro-Dex, Inc.'s (NASDAQ:PDEX) P/E Is Still On The Mark Following 37% Share Price Bounce

The Returns On Capital At Pro-Dex (NASDAQ:PDEX) Don't Inspire Confidence

Jul 18
The Returns On Capital At Pro-Dex (NASDAQ:PDEX) Don't Inspire Confidence

Investors Can Find Comfort In Pro-Dex's (NASDAQ:PDEX) Earnings Quality

Feb 16
Investors Can Find Comfort In Pro-Dex's (NASDAQ:PDEX) Earnings Quality

Here's Why Pro-Dex (NASDAQ:PDEX) Can Manage Its Debt Responsibly

Feb 14
Here's Why Pro-Dex (NASDAQ:PDEX) Can Manage Its Debt Responsibly

Pro-Dex, Inc.'s (NASDAQ:PDEX) Price Is Right But Growth Is Lacking After Shares Rocket 26%

Jan 24
Pro-Dex, Inc.'s (NASDAQ:PDEX) Price Is Right But Growth Is Lacking After Shares Rocket 26%

Pro-Dex (NASDAQ:PDEX) Has A Pretty Healthy Balance Sheet

May 20
Pro-Dex (NASDAQ:PDEX) Has A Pretty Healthy Balance Sheet

Pro-Dex (NASDAQ:PDEX) Could Be Struggling To Allocate Capital

Oct 05
Pro-Dex (NASDAQ:PDEX) Could Be Struggling To Allocate Capital

Pro-Dex: Growth Trends In Earnings, Return On Investment Contracting

Sep 26

When Should You Buy Pro-Dex, Inc. (NASDAQ:PDEX)?

Sep 20
When Should You Buy Pro-Dex, Inc. (NASDAQ:PDEX)?

Pro-Dex GAAP EPS of $0.38, revenue of $12.61M

Aug 25

Is Now The Time To Look At Buying Pro-Dex, Inc. (NASDAQ:PDEX)?

May 10
Is Now The Time To Look At Buying Pro-Dex, Inc. (NASDAQ:PDEX)?

Is Pro-Dex (NASDAQ:PDEX) Using Too Much Debt?

Apr 21
Is Pro-Dex (NASDAQ:PDEX) Using Too Much Debt?

Pro-Dex (NASDAQ:PDEX) Is Doing The Right Things To Multiply Its Share Price

Mar 14
Pro-Dex (NASDAQ:PDEX) Is Doing The Right Things To Multiply Its Share Price

Is Pro-Dex, Inc. (NASDAQ:PDEX) Potentially Undervalued?

Feb 09
Is Pro-Dex, Inc. (NASDAQ:PDEX) Potentially Undervalued?

We Think Pro-Dex (NASDAQ:PDEX) Is Taking Some Risk With Its Debt

Nov 17
We Think Pro-Dex (NASDAQ:PDEX) Is Taking Some Risk With Its Debt

Is It Too Late To Consider Buying Pro-Dex, Inc. (NASDAQ:PDEX)?

Aug 29
Is It Too Late To Consider Buying Pro-Dex, Inc. (NASDAQ:PDEX)?

A History Of Strong Growth Rates: Pro-Dex On Sale

Aug 25

The Return Trends At Pro-Dex (NASDAQ:PDEX) Look Promising

May 18
The Return Trends At Pro-Dex (NASDAQ:PDEX) Look Promising

What Is Pro-Dex, Inc.'s (NASDAQ:PDEX) Share Price Doing?

Mar 29
What Is Pro-Dex, Inc.'s (NASDAQ:PDEX) Share Price Doing?

Is Weakness In Pro-Dex, Inc. (NASDAQ:PDEX) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Mar 15
Is Weakness In Pro-Dex, Inc. (NASDAQ:PDEX) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

The Pro-Dex (NASDAQ:PDEX) Share Price Is Up 732% And Shareholders Are Delighted

Feb 26
The Pro-Dex (NASDAQ:PDEX) Share Price Is Up 732% And Shareholders Are Delighted

Independent Director William Farrell Just Sold A Bunch Of Shares In Pro-Dex, Inc. (NASDAQ:PDEX)

Feb 13
Independent Director William Farrell Just Sold A Bunch Of Shares In Pro-Dex, Inc. (NASDAQ:PDEX)

We Like These Underlying Trends At Pro-Dex (NASDAQ:PDEX)

Feb 08
We Like These Underlying Trends At Pro-Dex (NASDAQ:PDEX)

Is Pro-Dex (NASDAQ:PDEX) A Risky Investment?

Jan 25
Is Pro-Dex (NASDAQ:PDEX) A Risky Investment?

Shareholder Returns

PDEXUS Medical EquipmentUS Market
7D-3.4%0.09%-0.3%
1Y138.0%7.7%8.1%

Return vs Industry: PDEX exceeded the US Medical Equipment industry which returned 7.7% over the past year.

Return vs Market: PDEX exceeded the US Market which returned 8.1% over the past year.

Price Volatility

Is PDEX's price volatile compared to industry and market?
PDEX volatility
PDEX Average Weekly Movement13.9%
Medical Equipment Industry Average Movement9.7%
Market Average Movement8.0%
10% most volatile stocks in US Market16.6%
10% least volatile stocks in US Market4.2%

Stable Share Price: PDEX's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: PDEX's weekly volatility (14%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
1978147Rick Van Kirkwww.pro-dex.com

Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries.

Pro-Dex, Inc. Fundamentals Summary

How do Pro-Dex's earnings and revenue compare to its market cap?
PDEX fundamental statistics
Market capUS$144.43m
Earnings (TTM)US$9.37m
Revenue (TTM)US$64.12m

15.4x

P/E Ratio

2.3x

P/S Ratio

Is PDEX overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PDEX income statement (TTM)
RevenueUS$64.12m
Cost of RevenueUS$44.02m
Gross ProfitUS$20.11m
Other ExpensesUS$10.74m
EarningsUS$9.37m

Last Reported Earnings

Mar 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)2.87
Gross Margin31.36%
Net Profit Margin14.61%
Debt/Equity Ratio51.8%

How did PDEX perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/11 12:33
End of Day Share Price 2025/05/09 00:00
Earnings2025/03/31
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Pro-Dex, Inc. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Edward WooAscendiant Capital Markets LLC